Skip to main content
. 2010 Oct 14;10:81. doi: 10.1186/1471-244X-10-81

Table 4.

Predictors at baseline for changes at follow-ups in QoL in SAD patients treated with CBT

Characteristics Post treatment 3-month follow-up 12-month follow-up
at baseline PF RP BP GH VT SF RE MH PF RP BP GH VT SF RE MH PF RP BP GH VT SF RE MH

Adjusted R-square 0.62 0.12 0.17 0.39 0.50 0.27 0.15 0.41 0.45 0.25 0.23 0.47 0.59 0.36 0.19 0.32 0.64 0.21 0.33 0.29 0.46 0.55 0.35 0.37

Age: 35 yrs or older a a a a a a 0.41* a a a a a a a a a a a a a a a a a
Living situation a a a a -0.32** a a a a a a a a a a a a a a a a a a a
Employment a a a a a a a a a a a a -0.30* a a a a a a a a a a a
Generalized SAD -0.22* a a a a a a -0.28* a a a a a a a a a a a a a a a a
Benzodiazepine use 0.23* a a a a a a a a a a a a a a a a a a a a a a a
SPS (total) a a a a a a a a a 0.39* a 0.29* a a a a a a a a a 0.49** a a
SIAS (total) a a a a a a a a a a a a a a a a a a a a a -0.32* a a
SCL-90-R depression a a -0.44** a a a a a a -0.64** a a a a -0.46** a a a a a a -0.41* -0.61** a

Table shows the standardized Beta coefficients, except for a row showing adjusted R-squares of the models. Sex, age of onset (20 years or older), marital status, education, comorbid mood or anxiety disorder, and antidepressant use were entered but not selected in any regression models through application of a stepwise method.

a Entered into the analysis but not selected in the multiple regression model through application of a stepwise method.

Appendices: PF, physical functioning; RP, role physical; BP, bodily pain; GH, general health perception; VT, vitality; SF, social functioning; RE, role emotional; MH, mental health; SAD, social anxiety disorder; SCL-90-R, Symptom Checklist-90-Revised; SF-36, Short Form 36; SIAS, Social Interaction Anxiety; SPS, Social Phobia Scale

(* P < 0.05, ** P < 0.005)